Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00576355 · ClinicalTrials.gov registry record · NA

Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder

A NA study of Bipolar Disorder, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT00576355: Completed NA study of Bipolar Disorder, sponsored by University of Washington.

NCT00576355 is a NA study of Bipolar Disorder that has completed, run by University of Washington. The registered enrollment target is 36 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00576355, a NA study of Bipolar Disorder, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of interpersonal and social rhythm therapy in treating adolescents with a bipolar spectrum disorder

Conditions Studied

Interventions

  • BEHAVIORAL Treatment As Usual (TAU)
  • BEHAVIORAL Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A)

Study Locations (1)

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2007-12
Est. Completion 2010-08
Phase NA
University of Washington

1,048 total trials

What the finished NCT00576355 record still lists

NCT00576355 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual (TAU) is the first listed.

NCT00576355 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00576355 about?

NCT00576355 is a clinical study titled "Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder". This study will evaluate the effectiveness of interpersonal and social rhythm therapy in treating adolescents with a bipolar spectrum disorder

What is the current status of trial NCT00576355?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2007-12. Estimated completion is 2010-08.

What conditions does trial NCT00576355 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT00576355?

The interventions under investigation include: Treatment As Usual (TAU) (BEHAVIORAL), Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00576355?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00576355 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00576355's enrollment target sits among peer trials

36 129th of 162 higher than 33 of 162 other Bipolar Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00576355, the US trial registry maintained by the National Library of Medicine. NCT00576355 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.